Drug Trial Radar · NCT00134030
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Last checked: Nov 20, 2026Latest source record: Jun 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,334
Actual
Start
Nov 14, 2005
Primary completion
Jan 31, 2015
Study completion Sep 30, 2022
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI); University College, London; Medical Research Council
- First posted
- Aug 24, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 5 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial is studying combination chemotherapy followed by surgery and two different combination chemotherapy regimens with or without PEG-interferon alfa-2b to compare how well they work in treating patients with osteosarcoma. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Biological therapies, such as PEG-interferon alfa-2b, may interfere with the growth of tumor cells. Giving combination chemotherapy before surgery may shrink the tumor so it can be removed. Giving combination chemotherapy together with PEG-interferon alfa-2b after surgery may kill any remaining tumor cells. It is not yet known whether giving combination therapy together with PEG-interferon alfa-2b is more effective than two different combination chemotherapy regimens alone after surgery in treating osteosarcoma.
Conditions
- Localized Osteosarcoma
- Metastatic Osteosarcoma
Interventions
CisplatinDrug
Given IV
Doxorubicin HydrochlorideDrug
Given IV
EtoposideDrug
Given IV
IfosfamideDrug
Given IV
MethotrexateDrug
Given IV
Peginterferon Alfa-2bBiological
Given subcutaneously
Quality-of-Life AssessmentOther
Ancillary studies
Questionnaire AdministrationOther
Ancillary studies
Therapeutic Conventional SurgeryProcedure
Undergo amputation or limb salvage surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free Survival (EFS)Time frame: From date of randomization to date of the event.
Locations
218 sites in 6 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Phoenix Childrens Hospital
Phoenix, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Kaiser Permanente Downey Medical Center
Downey, California
City of Hope Comprehensive Cancer Center
Duarte, California
Loma Linda University Medical Center
Loma Linda, California
Miller Children's and Women's Hospital Long Beach
Long Beach, California
Children's Hospital Los Angeles
Los Angeles, California
Cedars Sinai Medical Center
Los Angeles, California
Mattel Children's Hospital UCLA
Los Angeles, California
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California
Valley Children's Hospital
Madera, California
Children's Hospital and Research Center at Oakland
Oakland, California
Kaiser Permanente-Oakland
Oakland, California
Children's Hospital of Orange County
Orange, California
Lucile Packard Children's Hospital Stanford University
Palo Alto, California
Sutter Medical Center Sacramento
Sacramento, California
University of California Davis Comprehensive Cancer Center
Sacramento, California
Rady Children's Hospital - San Diego
San Diego, California
UCSF Medical Center-Mount Zion
San Francisco, California
UCSF Medical Center-Parnassus
San Francisco, California
UCSF Medical Center-Mission Bay
San Francisco, California
Harbor-University of California at Los Angeles Medical Center
Torrance, California
Children's Hospital Colorado
Aurora, Colorado
University of Connecticut
Farmington, Connecticut
Connecticut Children's Medical Center
Hartford, Connecticut
Yale University
New Haven, Connecticut
Alfred I duPont Hospital for Children
Wilmington, Delaware
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Children's National Medical Center
Washington D.C., District of Columbia
Broward Health Medical Center
Fort Lauderdale, Florida
Lee Memorial Health System
Fort Myers, Florida
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida
University of Florida Health Science Center - Gainesville
Gainesville, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida
Showing 40 of 218 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.